Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression

Proteomics

Volumn 13, Issue 2, 2013, Pages 379-388

  De Boeck, Astrid ^a   Hendrix, An ^a   Maynard, Dawn ^b   Van Bockstal, Mieke ^c   Daniëls, Annick ^d   Pauwels, Patrick ^e   Gespach, Christian ^f   Bracke, Marc ^a   De Wever, Olivier ^a  

^a Department of Radiation Oncology and Experimental Cancer Research ^*  (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d Laboratory of Experimental Hematology   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f CENTRE DE RECHERCHE SAINT ANTOINE   (France)

Author keywords

Cancer associated fibroblasts; Cell Biology; Colon cancer; Mesenchymal stem cells; MS; Secretome

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; CATHEPSIN D; FIBRONECTIN; PROTEOME; RANTES; SECRETOME; STROMAL CELL DERIVED FACTOR 1ALPHA; STROMELYSIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; COLON CANCER; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; TUMOR MICROENVIRONMENT;

BONE MARROW CELLS; COLONIC NEOPLASMS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMAL CELLS; NEOPLASM PROTEINS; PHENOTYPE; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84872685152     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200179     Document Type: Article

References (39)

1. Siegel, R., Naishadham, D., Jemal, A., Cancer statistics. CA Cancer J. Clin. 2012, 62, 10-29.
2. De Wever, O., Mareel, M., Role of tissue stroma in cancer cell invasion. J. Pathol. 2003, 200, 429-447.
3. De Wever, O., Demetter, P., Mareel, M., Bracke, M., Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 2008, 123, 2229-2238.
4. De Wever, O., Nguyen, Q. D., Van Hoorde, L., Bracke, M. et al., Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J. 2004, 18, 1016-1018.
5. Hinz, B., Phan, S. H., Thannickal, V. J., Prunotto, M. et al., Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180, 1340-1355.
6. De Boeck, A., Narine, K., De Neve, W., Mareel, M. et al., Resident and bone marrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma. Oral Oncol. 2010, 46, 336-342.
7. Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A. et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449, 557-563.
8. Quante, M., Tu, S. P., Tomita, H., Gonda, T. et al., Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell. 2011, 19, 257-272.
9. Spaeth, E. L., Dembinski, J. L., Sasser, A. K., Watson, K. et al., Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PloS One 2009, 4, e4992.
10. De Boeck, A., Pauwels, P., Hensen, K., Rummens, J. L. et al., Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut. 2012, doi: 10.1136/gutjnl-2011-301393.
11. Finak, G., Bertos, N., Pepin, F., Sadekova, S. et al., Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 2008, 14, 518-527.
12. Escher, N., Ernst, G., Melle, C., Berndt, A. et al., Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS). Diagn. Pathol. 2010, 5, 10.
13. Planche, A., Bacac, M., Provero, P., Fusco, C. et al., Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer. PloS One 2011, 6, e18640.
14. Singer, C. F., Gschwantler-Kaulich, D., Fink-Retter, A., Haas, C. et al., Differential gene expression profile in breast cancer-derived stromal fibroblasts. Breast Cancer Res. Treat 2008, 110, 273-281.
15. Volmer, M. W., Stühler, K., Zapatka, M., Schöneck, A. et al., Differential proteome analysis of conditioned media to detect Smad4 regulated secreted biomarkers in colon cancer. Proteomics 2005, 5, 2587-2601.
16. Hathout, Y., Approaches to the study of the cell secretome. Expert Rev. Proteomics 2007, 4, 239-248.
17. Koninckx, R., Hensen, K., Daniels, A., Moreels, M. et al., Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy 2009, 11, 778-792.
18. Kolf, C. M., Cho, E., Tuan, R. S., Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis Res. Ther. 2007, 9, 204.
19. Dominici, M., Blanc, K. L., Mueller, I., Slaper-Cortenbach, I. et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8, 315-317.
20. Majd, H., Wipff, P. J., Buscemi, L., Bueno, M. et al., A novel method of dynamic culture surface expansion improves mesenchymal stem cell proliferation and phenotype. Stem. Cells 2009, 27, 200-209.
21. De Wever, O., Hendrix, A., De Boeck, A., Westbroek, W. et al., Modeling and quantification of cancer cell invasion through collagen type I matrices. Int. J. Dev. Biol. 2010, 54, 887-896.
22. Maynard, D. M., Heijnen, H. F. G., Horne, M. K., White, J. G. et al., Proteomic analysis of platelet α-granules using mass spectrometry. J. Thromb. Haemost. 2007, 5, 1945-1955.
23. Perkins, D. N., Pappin, D. J. C., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
24. Garbis, S., Lubec, G., Fountoulakis, M., Limitations of current proteomics technologies. J. Chromatogr. A 2005, 1077, 1-18.
25. Guo, X., Wang, X. F., Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 2009, 19, 71-88.
26. Narine, K., De Wever, O., Van Valckenborgh, D., Francois, K. et al., Growth factor modulation of fibroblast proliferation, differentiation, and invasion: implications for tissue valve engineering. Tissue Eng. 2006, 12, 2707-2716.
27. Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M. et al., In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp. Cell. Res. 1998, 238, 265-272.
28. Solorio, L. D., Fu, A. S., Hernández-Irizarry, R., Alsberg, E., Chondrogenic differentiation of human mesenchymal stem cell aggregates via controlled release of TGF-β1 from incorporated polymer microspheres. J. Biomed. Mater Res. A 2009, 92A, 1139-1144.
29. Bauer, M., Su, G., Casper, C., He, R. et al., Heterogeneity of gene expression in stromal fibroblasts of human breast carcinomas and normal breast. Oncogene 2010, 29, 1732-1740.
30. Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F. et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121, 335-348.
31. Verrecchia, F., Chu, M. L., Mauviel, A., Identification of novel TGF-beta/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J. Biol. Chem. 2001, 276, 17058-17062.
32. Bootcov, M. R., Bauskin, A. R., Valenzuela, S. M., Moore, A. G. et al., MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc. Natl. Acad. Sci. USA 1997, 94, 11514-11519.
33. Zielske, S. P., Livant, D. L., Lawrence, T. S., Radiation increases invasion of gene-modified mesenchymal stem cells into tumors. Int. J. Radiat. Oncol. Biol. Phys. 2009, 75, 843-853.
34. Saigusa, S., Toiyama, Y., Tanaka, K., Yokoe, T. et al., Cancer-associated fibroblasts correlate with poor prognosis in rectal cancer after chemoradiotherapy. Int. J. Oncol. 2011, 38, 655-663.
35. Riedl, S., Bodenmuller, H., Hinz, U., Holle, R. et al., Significance of tenascin serum level as tumor marker in primary colorectal carcinoma. Int. J. Cancer 1995, 64, 65-69.
36. Paulitschke, V., Kunstfeld, R., Mohr, T., Slany, A. et al., Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells. J. Proteome Res. 2009, 8, 2501-2510.
37. Sardana, G., Jung, K., Stephan, C., Diamandis, E. P., Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J. Proteome Res. 2008, 7, 3329-3338.
38. Rocco, M., Malorni, L., Cozzolino, R., Palmieri, G. et al., Proteomic profiling of human melanoma metastatic cell line secretomes. J. Proteome Res. 2011, 10, 4703-4714.
39. Choi, Y. A., Lim, J., Kim, K. M., Acharya, B. et al., Secretome analysis of human BMSCs and identification of SMOC1 as an important ECM protein in osteoblast differentiation. J. Proteome Res. 2010, 9, 2946-2956.